Related Experiment Video
Updated: May 4, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
[Cardiac tamponade as first manifestation in Mediterranean fever with autosomal dominant form]
F Sánchez Ferrer1, M Martinez Villar2, A Fernández Bernal2
1Servicio de Pediatría, Hospital Universitario de San Juan, Alicante, España.
Abstract:
Familial Mediterranean fever (FMF) is a hereditary disease characterized by brief, recurring and self-limited episodes of fever and pain with inflammation, of one or several serous (peritoneum, pleura, pericardium, synovial or vaginal tunic of the testicle). Amyloidosis is its more important complication and the principal reason of death in the cases in which it appears. Diagnosis is based on the clinic and is confirmed by genetic tests. The treatment with Colchicine (0,02-0,03 mg/kg/day) prevents the recurrence of FMF attacks and the development of secondary (AA) amyloidosis. We report a case of a 13-year-old child in which FMF was diagnosed after several coincidental episodes with fever, pericarditis and cardiac tamponade. The genetic confirmation showed an autosomal dominant inheritance that is less frecuent than the recesive form, in this disease.
Insights
Familial Mediterranean fever (FMF) is a rare genetic disorder causing recurrent fevers and inflammation. Early diagnosis and colchicine treatment are crucial for preventing severe complications like amyloidosis.
Area of Science:
- Genetics
- Rheumatology
- Pediatrics
Background:
- Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
- Characterized by recurrent episodes of fever, serositis, and inflammation.
- Amyloidosis is a significant complication, leading to organ damage and mortality.
Observation:
- A 13-year-old child presented with recurrent fevers, pericarditis, and cardiac tamponade.
- Diagnosis of FMF was established following these episodes.
- Genetic testing revealed an autosomal dominant inheritance pattern.
Findings:
- The patient's FMF diagnosis was confirmed through clinical presentation and genetic testing.
- The identified autosomal dominant inheritance is less common than the recessive form.
- Colchicine treatment is standard for preventing FMF attacks and amyloidosis.
Implications:
- Highlights the importance of considering FMF in pediatric cases with recurrent serositis and cardiac involvement.
- Emphasizes the diagnostic value of genetic testing for FMF, especially in atypical inheritance patterns.
- Reinforces the efficacy of colchicine in managing FMF and preventing severe complications like amyloidosis.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy

